EXENCIAL WEALTH ADVISORS, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXENCIAL WEALTH ADVISORS, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$15,276,741
-2.9%
149,978
-3.8%
0.74%
+2.5%
Q2 2023$15,727,060
+1.4%
155,852
-7.5%
0.72%
-10.0%
Q1 2023$15,505,202
-2.6%
168,535
-4.0%
0.80%
-6.3%
Q4 2022$15,926,003
+17.6%
175,551
-1.5%
0.86%
+4.4%
Q3 2022$13,548,000
+1.2%
178,238
+12.6%
0.82%
+8.5%
Q2 2022$13,382,000
-4.9%
158,313
-1.3%
0.76%
+6.9%
Q1 2022$14,077,000
-10.8%
160,423
-11.1%
0.71%
-7.5%
Q4 2021$15,788,000
-32.4%
180,499
-36.8%
0.76%
-24.7%
Q3 2021$23,370,000
+24.2%
285,767
+38.6%
1.02%
-0.2%
Q2 2021$18,809,000
-0.7%
206,151
-7.0%
1.02%
-9.4%
Q1 2021$18,951,000
+0.4%
221,696
+10.9%
1.12%
-12.8%
Q4 2020$18,872,000
-6.6%
199,854
-14.0%
1.29%
+20.3%
Q3 2020$20,207,000
+4.4%
232,371
+4.9%
1.07%
-36.1%
Q2 2020$19,352,000
+7.9%
221,566
+1.9%
1.68%
-47.6%
Q1 2020$17,934,000
-9.2%
217,509
+4.2%
3.20%
-6.5%
Q4 2019$19,760,000
+20.7%
208,685
+10.7%
3.42%
-2.8%
Q3 2019$16,376,000
+11.1%
188,442
+16.7%
3.52%
+2.4%
Q2 2019$14,740,000
-5.3%
161,429
-0.2%
3.44%
-6.9%
Q1 2019$15,558,000
-8.5%
161,824
-18.3%
3.69%
-19.0%
Q4 2018$16,995,000
-1.8%
198,056
-1.4%
4.56%
+13.3%
Q3 2018$17,303,000
+12.1%
200,826
-1.7%
4.02%
-6.4%
Q2 2018$15,433,000
-2.6%
204,308
+4.3%
4.30%
-8.7%
Q1 2018$15,839,000
-3.8%
195,903
-0.1%
4.71%
-5.0%
Q4 2017$16,466,000
+8.8%
196,122
+11.3%
4.96%
-0.5%
Q3 2017$15,131,000
+3.6%
176,254
+0.7%
4.98%
-16.7%
Q2 2017$14,610,000
+6.5%
175,039
-7.1%
5.98%
+0.6%
Q1 2017$13,713,000
+5.6%
188,514
+5.7%
5.95%
+8.1%
Q4 2016$12,988,000
-7.1%
178,313
-9.4%
5.50%
-11.2%
Q3 2016$13,985,000
+6.2%
196,909
+23.4%
6.19%
+4.3%
Q2 2016$13,165,000
+42.4%
159,551
+25.0%
5.94%
+36.3%
Q1 2016$9,245,000
-0.6%
127,626
+12.0%
4.35%
-5.8%
Q4 2015$9,303,000
-13.4%
113,957
-2.5%
4.62%
-12.0%
Q3 2015$10,747,000
-2.3%
116,917
+9.5%
5.25%
-24.5%
Q2 2015$11,002,000
+7.0%
106,763
+7.3%
6.96%
+61.3%
Q1 2015$10,280,000
+12.4%
99,510
+4.6%
4.31%
+6.5%
Q4 2014$9,142,000
+1.3%
95,115
-0.8%
4.05%
+1.6%
Q3 2014$9,029,000
+6.8%
95,919
+2.2%
3.98%
+10.7%
Q2 2014$8,457,000
+12.8%
93,890
+5.7%
3.60%
+14.8%
Q1 2014$7,498,000
-15.4%
88,827
-19.0%
3.14%
-22.0%
Q4 2013$8,863,000
+320.8%
109,700
+301.0%
4.02%
+307.4%
Q3 2013$2,106,000
+33.8%
27,355
+28.3%
0.99%
+26.4%
Q2 2013$1,574,000
+5.4%
21,329
+5.3%
0.78%
+23.6%
Q1 2013$1,494,00020,2490.63%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders